Prognostic Value of Serum AFP, AFP-L3, and GP73 in Monitoring Short-term Treatment Response and Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic Value of Serum AFP, AFP-L3, and GP73 in Monitoring Short-term Treatment Response and Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation
Authors
Keywords
-
Journal
Asian Pacific Journal of Cancer Prevention
Volume 15, Issue 4, Pages 1539-1544
Publisher
Asian Pacific Organization for Cancer Prevention
Online
2014-07-10
DOI
10.7314/apjcp.2014.15.4.1539
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2015) et al. JOURNAL OF HEPATOLOGY
- Can Glypican3 be Diagnostic for Early Hepatocellular Carcinoma among Egyptian Patients?
- (2014) Iman Attia Abdelgawad et al. Asian Pacific Journal of Cancer Prevention
- Percutaneous Radiofrequency Ablation Guided by Contrast-enhanced Ultrasound in Treatment of Metastatic Hepatocellular Carcinoma after Liver Transplantation
- (2013) Xin Dai et al. Asian Pacific Journal of Cancer Prevention
- Rising Incidence of Primary Liver Cancer in Brunei Darussalam
- (2013) Raymond Jih Yeong Chong et al. Asian Pacific Journal of Cancer Prevention
- Value of Highly Sensitive Fucosylated Fraction of Alpha-Fetoprotein for Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment
- (2013) Yasushi Tamura et al. DIGESTIVE DISEASES AND SCIENCES
- Recently introduced biomarkers for screening of hepatocellular carcinoma: a systematic review and meta-analysis
- (2012) Caroline D. M. Witjes et al. Hepatology International
- Prediction of recurrence of hepatocellular carcinoma after curative hepatectomy using preoperative Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein
- (2012) Yu Saito et al. HEPATOLOGY RESEARCH
- Frequency of Elevated Hepatocellular Carcinoma (HCC) Biomarkers in Patients With Advanced Hepatitis C
- (2011) Richard K Sterling et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein
- (2011) Hidenori Toyoda et al. CANCER SCIENCE
- Prognostic importance of fucosylated alpha-fetoprotein in hepatocellular carcinoma patients with low alpha-fetoprotein
- (2011) Kazuhiro Nouso et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma
- (2010) Yilei Mao et al. GUT
- AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC
- (2010) Kentaroh Yamamoto et al. JOURNAL OF GASTROENTEROLOGY
- Significance of Alpha-Fetoprotein and Des-γ-Carboxy Prothrombin in Patients with Hepatocellular Carcinoma Undergoing Hepatectomy
- (2009) Kentaroh Yamamoto et al. ANNALS OF SURGICAL ONCOLOGY
- Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas
- (2009) Marc-Oliver Riener et al. HEPATOLOGY
- GP73, a resident Golgi glycoprotein, is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population
- (2009) Jin-song Hu et al. MEDICAL ONCOLOGY
- Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics
- (2009) Mohamed IF Shariff et al. Expert Review of Gastroenterology & Hepatology
- EpCAM and -Fetoprotein Expression Defines Novel Prognostic Subtypes of Hepatocellular Carcinoma
- (2008) T. Yamashita et al. CANCER RESEARCH
- Liver Transplantation for Hepatocellular Carcinoma: Impact of the MELD Allocation System and Predictors of Survival
- (2008) George N. Ioannou et al. GASTROENTEROLOGY
- Trends in mortality from hepatocellular carcinoma in Europe, 1980‐2004
- (2008) Cristina Bosetti et al. HEPATOLOGY
- Des-γ-carboxyprothrombin, α-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma
- (2008) Francisco A Durazo et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC
- (2008) Hidenori Toyoda et al. JOURNAL OF HEPATOLOGY
- Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. JNCI-Journal of the National Cancer Institute
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started